|

Disease Containment Measures Among Older Adults During the Covid-19 Pandemia

RECRUITINGSponsored by Norwegian Centre for Ageing and Health
Actively Recruiting
SponsorNorwegian Centre for Ageing and Health
Started2021-02-18
Est. completion2024-03-20
Eligibility
Age70 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04792086

Summary

This study will examine which impact lockdown strategies intending to prevent the spread of COVID-19 had on people with cognitive impairment and dementia. Comprehensive data from two large health studies in Norway, conducted before and after the COVID-19 outbreak, will be linked with health register data on the use of health care services and medication. Further, it will be conducted a survey addressing questions on social isolation and use of communicative technology, from March 2020 to January 2021. The knowledge gained from this study can improve the health care system's ability to respond more adequately to pandemics and other unforeseen events, so that the negative consequences for older adults with dementia and cognitive impairment can be reduced.

Eligibility

Age: 70 Years+Healthy volunteers accepted
Inclusion Criteria:

* Inhabitants living in the designated areas

Exclusion Criteria:

* None

Conditions6

AnxietyCognitive ImpairmentDementiaDepressionDepression, AnxietyLoneliness

Browse More Trials

Depression trialsAnxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.